Preparation and characterization of adefovir dipivoxil–stearic acid cocrystal with enhanced physicochemical properties
- 11 June 2017
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 23 (9) , 890-899
Abstract
The objectives of this study were to prepare cocrystal composed of adefovir dipivoxil (AD) and stearic acid (SA) and to investigate the enhanced properties of the cocrystal. The cocrystal was prepared by antisolvent precipitation and characterized by scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR), X-ray powder diffraction (XRPD), and differential scanning calorimetry (DSC). The enhanced properties were evaluated by dissolution testing, permeability studies, and powder rheology analysis. The AD raw material has a cuboid-like crystal and the cocrystal has a needle shape. In the FT-IR study, there were bathochromic shifts caused by the hydrogen bonding. The melting point of the cocrystal was 52.9 °C, which was lower than that of AD. The XRPD pattern also had distinct differences, supporting the formation of a new crystalline form. The cocrystal showed changes in the lattice energy and the solvation strength, which caused an enhanced dissolution. The permeability was increased due to the SA, which acts as a P-gp inhibitor. The tabletability was enhanced due to the altered crystal habit. In conclusion, cocrystal containing AD and SA was successfully prepared, presenting advantages such as enhanced solubility, tabletability, and permeability. The use of the cocrystal is a desirable approach for the improved physicochemical properties.Keywords
Funding Information
- Ministry of Health, Welfare and Family Affairs (HI09C1323)
This publication has 46 references indexed in Scilit:
- Characteristics of indomethacin–saccharin (IMC–SAC) co-crystals prepared by an anti-solvent crystallization processEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Pharmaceutical Cocrystals: The Coming Wave of New Drug SubstancesJournal of Pharmaceutical Sciences, 2013
- Simultaneously Improving the Mechanical Properties, Dissolution Performance, and Hygroscopicity of Ibuprofen and Flurbiprofen by Cocrystallization with NicotinamidePharmaceutical Research, 2012
- The emerging role of P-glycoprotein inhibitors in drug delivery: a patent reviewExpert Opinion on Therapeutic Patents, 2011
- Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1 : 1 co-crystalCrystEngComm, 2010
- Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdvanced Drug Delivery Reviews, 2007
- Pharmaceutical Cocrystal and Salts of NorfloxacinCrystal Growth & Design, 2006
- Determining the compression behaviour of pharmaceutical powders from the force–distance compression profileInternational Journal of Pharmaceutics, 2003
- Influence of crystal habit on the compression and densification mechanism of ibuprofenJournal of Crystal Growth, 2002
- Carrier Mechanisms Involved in the Transepithelial Transport of bis(POM)-PMEA and Its Metabolites Across Caco-2 MonolayersPharmaceutical Research, 1998